Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Low convergent validity of [11C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [11C]FLB 457

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Using connectomics for predictive assessment of brain parcellations

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Concurrent TMS-fMRI for causal network perturbation and proof of target engagement

    Research output: Contribution to journalReviewResearchpeer-review

  3. Prospective frequency and motion correction for edited 1H magnetic resonance spectroscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A high-resolution in vivo atlas of the human brain's benzodiazepine binding site of GABAA receptors

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Serotonin transporter availability increases in patients recovering from a depressive episode

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nondisplaceable Binding Is a Potential Confounding Factor in C-11-PBR28 Translocator Protein PET Studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Tove Freiburghaus
  • Jonas E Svensson
  • Granville J Matheson
  • Pontus Plavén-Sigray
  • Johan Lundberg
  • Lars Farde
  • Simon Cervenka
View graph of relations

Dopamine D2 receptors (D2-R) in extrastriatal brain regions are of high interest for research in a wide range of psychiatric and neurologic disorders. Pharmacological competition studies and test-retest experiments have shown high validity and reliability of the positron emission tomography (PET) radioligand [11C]FLB 457 for D2-R quantification in extrastriatal brain regions. However, this radioligand is not available at most research centers. Instead, the medium affinity radioligand [11C]raclopride, which has been extensively validated for quantification of D2-R in the high-density region striatum, has been applied also in studies on extrastriatal D2-R. Recently, the validity of this approach has been questioned by observations of low occupancy of [11C]raclopride in extrastriatal regions in a pharmacological competition study with quetiapine. Here, we utilise a data set of 16 healthy control subjects examined with both [11C]raclopride and [11C]FLB 457 to assess the correlation in binding potential (BPND) in extrastriatal brain regions. BPND was quantified using the simplified reference tissue model with cerebellum as reference region. The rank order of mean regional BPND values were similar for both radioligands, and corresponded to previously reported data, both post-mortem and using PET. Nevertheless, weak to moderate within-subject correlations were observed between [11C]raclopride and [11C]FLB 457 BPND extrastriatally (Pearson's R: 0.30-0.56), in contrast to very strong correlations between repeated [11C]FLB 457 measurements (Pearson's R: 0.82-0.98). In comparison, correlations between repeated [11C]raclopride measurements were low to moderate (Pearson's R: 0.28-0.75). These results are likely related to low signal to noise ratio of [11C]raclopride in extrastriatal brain regions, and further strengthen the recommendation that extrastriatal D2-R measures obtained with [11C]raclopride should be interpreted with caution.

Original languageEnglish
Article number117523
Pages (from-to)117523
Publication statusPublished - 1 Feb 2021

    Research areas

  • Brain Mapping/methods, Brain/metabolism, Carbon Radioisotopes/metabolism, Dopamine Antagonists/metabolism, Female, Humans, Male, Middle Aged, Positron-Emission Tomography/methods, Pyrrolidines/metabolism, Raclopride/metabolism, Radioligand Assay/methods, Radiopharmaceuticals/metabolism, Receptors, Dopamine D2/analysis, Salicylamides/metabolism, Validation, Raclopride, Dopamine, D2-receptor, Extrastriatal, PET

ID: 67562397